what is the difference between propionyl-l-carnitine and l-carnitine hydrochloride | CAS 119793-66-7 VitaMonk GlycoTrax™ GPLC Extra Large
Description
It noncompetitively inhibits CD38s NAD+ hydrolase and cyclase activities, leading to the maintenance or increase of NAD+ levels in cells
10.1002/bit.1121
[DOI] [PubMed] [Google Scholar] 85.Lushchak VI
However, it must be carefully evaluated as there might be unwanted side effects of the treatment
For a 2 mg vial, use 1 mL (gives 2 mg/mL or 2,000 mcg/mL)
